To control an asthma patient’s symptoms, doctors will prescribe an inhaler to stop symptoms from cropping up and a rescue inhaler to be used if patients find themselves in the middle of an asthma attack.
“But if your rescue inhaler doesn’t give you the relief that you need, your next recourse is to go to the emergency room and get a breathing treatment. When you walk in that emergency room, the costs start at about $1,500,” medtech veteran Arik Anderson told Drug Delivery Business News. “These are avoidable healthcare costs.”
The root of the issue is that people are not properly taking their medications, according to Anderson. It’s not just affecting patient outcomes, either – medication nonadherence is a $300 billion problem in the U.S., he said.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.